<HTML>
<HEAD>
<TITLE>S-8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>As filed with the Securities and Exchange Commission on February&nbsp;14, 2006</B>

</DIV>

<DIV align="right" style="font-size: 10pt; margin-top: 6pt"><B>Registration No.&nbsp;333-</B><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
</DIV>


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM S-8</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF 1933</B>
</DIV>

<DIV align="center" style="font-size: 20pt; margin-top: 12pt"><B>FRESENIUS
MEDICAL CARE &#038; CO. AG<BR>
KOMMANDITGESELLSCHAFT auf AKTIEN (KGaA)</B>
</DIV>

<DIV align="center" style="font-size: 10pt"><B>(Exact name of registrant as specified in its charter)</B></DIV>


<DIV align="center" style="font-size: 20pt; margin-top: 12pt"><B>FRESENIUS MEDICAL CARE AG &#038; Co. KGaA
</B></DIV>
<DIV align="center" style="font-size: 10pt; margin-top: 0pt">
<B>(Translation of Registrant&#146;s Name into English)</B></DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Germany<BR>
(State or other jurisdiction of<BR>
incorporation or organization)</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>Not Applicable<BR>
(I.R.S. Employer<BR>
Identification No.)</B></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Else-Kr&#246;ner-Strasse 1<BR>
61352 Bad Homburg v.d.H., Germany<BR>
Telephone: 011-49-6172-609-0<BR>
(Address of Principal Executive offices, including Zip Code)</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>FRESENIUS MEDICAL CARE AG 1996 STOCK INCENTIVE PLAN<BR>
FRESENIUS MEDICAL CARE AG 1998 STOCK INCENTIVE PLAN<BR>
FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT 2001 INTERNATIONAL STOCK INCENTIVE PLAN<BR>
(Full Title of the Plan)</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Dr.&nbsp;Ben J. Lipps<BR>
Fresenius Medical Care Holdings, Inc.<BR>
95 Hayden Avenue<BR>
Lexington, MA 02420<BR>
(781)&nbsp;402-9000<BR>
(Name, Address, including Zip Code, and Telephone Number, including Area Code, of Agent for Service)</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Copy to:<BR>
Charles F. Niemeth, Esq.<BR>
Baker &#038; McKenzie LLP<BR>
1114 Avenue of the Americas<BR>
New York, New York 10036<BR>
(212)&nbsp;626-4100</B></DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CALCULATION OF REGISTRATION FEE</B>

</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="1%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="4%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD><!-- VRule -->
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="6%">&nbsp;</TD>

    <TD width="1%">&nbsp;</TD>
</TR><TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="23" style="border-bottom: 3px double #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Proposed</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>maximum</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>maximum</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>Amount of</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>to be</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>offering price</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>aggregate</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>registration</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="center"><B>Title of securities to be registered</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>registered</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>per share</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>offering price</B></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3"><B>fee (2)</B></TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
                    <TD valign="top" style="border-top: 2px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">Ordinary Shares, no par value(1)
</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>

    <TD align="center" colspan="3" valign="bottom" style="border-top: 2px solid #000000">2,849,318</TD>

    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>


<TD align="center" colspan="3" valign="bottom" style="border-top: 2px solid #000000">$108.67</TD>

    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>


<TD align="center" colspan="3" valign="bottom" style="border-top: 2px solid #000000">$309,635,387</TD>

    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>


<TD align="center" colspan="3" valign="bottom" style="border-top: 2px solid #000000">$33,130.44</TD>

    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD valign="top" style="border-top: 2px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">Preference Shares, no par value(1)
</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" colspan="3" valign="bottom" style="border-top: 2px solid #000000">2,986,203</TD>

    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
<TD align="center" colspan="3" valign="bottom" style="border-top: 2px solid #000000">$102.04</TD>

    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>


<TD align="center" colspan="3" valign="bottom" style="border-top: 2px solid #000000">$304,712,154</TD>

    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>

<TD align="center" colspan="3" valign="bottom" style="border-top: 2px solid #000000">$32,605.56</TD>

    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD valign="top" style="border-top: 2px solid #000000"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="right" valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD nowrap align="right" valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="right" valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD nowrap colspan="3" align="center" valign="top" style="border-top: 2px solid #000000">Total:
</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>


<TD align="center" colspan="3" valign="bottom" style="border-top: 2px solid #000000">$65,736.00</TD>

    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="23" style="border-top: 3px double #000000">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">(1)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>American Depositary Receipts evidencing American Depositary Shares (&#147;ADSs&#148;) issuable upon
deposit of the Ordinary Shares and Preference Shares registered hereby have been registered
under separate registration statements on Form F-6.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">(2)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Proposed Maximum Aggregate Offering Price (estimated solely for purposes of computing the
registration fee) is calculated pursuant to Rule 457(h) under the Securities Act of 1933, as
amended, computed based upon a market value of &#128;91.05 per
ordinary share and <BR>
&#128;85.50 per preference share, calculated in each case by taking the average of the high and low prices
for such shares on the Frankfurt Stock Exchange on February&nbsp;8, 2006, converted to U.S. dollars
at the noon buying rate of &#128;1.00 = $1.935, as determined by the Board of Governors of the
Federal Reserve System on February&nbsp;8, 2006.</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PART I<BR>
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The document(s) containing the information specified in Part&nbsp;I of Form S-8 (plan
information and registrant information) will be sent or given to the participating employees as
specified by Rule&nbsp;428(b)(1) of the Securities Act of 1933, as amended (the &#147;Securities Act&#148;). Such
documents need not be filed with the Securities and Exchange Commission either as part of this
Registration Statement or as prospectuses or prospectus supplements pursuant to Rule&nbsp;424. These
documents, which include the statement of availability required by Item&nbsp;2 of Form S-8, and the
documents incorporated by reference herein pursuant to Item&nbsp;3 of Form S-8 (Part&nbsp;II hereof), as
applied to foreign issuers, taken together, constitute a prospectus that meets the requirements of
Section 10(a) of the Securities Act.
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PART II<BR>
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;3. Incorporation of Documents by Reference</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following documents, which have been filed by Fresenius Medical Care
Aktiengesellschaft (&#147;<B>Fresenius Medical Care AG</B>&#148;, or the &#147;<B>Predecessor</B>&#148;), the predecessor entity to
Fresenius Medical Care AG &#038; Co. Kommanditgesellschaft auf Aktien
(&#147;<B>FMC-AG &#38; Co. KGaA</B>&#148; or
the &#147;<B>Registrant</B>&#148;), with the Securities and Exchange Commission (the &#147;<B>Commission</B>&#148;), are incorporated
in this registration statement by reference, except as superseded or modified as described herein:
</DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(a)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Predecessor&#146;s latest annual report on Form 20-F (Commission file No.&nbsp;001-14444) for the fiscal year ended
December&nbsp;31, 2004, filed with the Commission on March&nbsp;1, 2005.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(b)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Predecessor&#146;s amended annual report on Form 20-F/A (Commission file No.&nbsp;001-14444) for the fiscal year ended
December&nbsp;31, 2004, filed with the Commission on July&nbsp;13, 2005.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(c)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Predecessor&#146;s report on Form 6-K for the month of July&nbsp;2005, furnished to the Commission on July&nbsp;5, 2005.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(d)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Predecessor&#146;s report on Form 6-K for the month of November&nbsp;2005, furnished to the Commission on November&nbsp;3, 2005
and containing the Predecessor&#146;s financial statements as of and for the nine months ended September&nbsp;30, 2005.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(e)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Predecessor&#146;s report on Form 6-K for the month of November&nbsp;2005, furnished to the Commission on November&nbsp;29, 2005.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(f)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Predecessor&#146;s report on Form 6-K for the month of December&nbsp;2005, furnished to the Commission on December&nbsp;1, 2005.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(g)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Predecessor&#146;s report on Form 6-K for the month of December&nbsp;2005, furnished to the Commission on December&nbsp;22, 2005.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(h)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Predecessor&#146;s report on Form 6-K for the month of December&nbsp;2005, furnished to the Commission on December&nbsp;23, 2005.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(i)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The Predecessor&#146;s report on Form 6-K for the month of January&nbsp;2006, furnished to the Commission on January&nbsp;3, 2006.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(j)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of the Ordinary Shares, including the descriptions of the American Depositary Receipts and the
Pooling Arrangements in the Company&#146;s Report on Form 8-K filed February&nbsp;13, 2006.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(k)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of the Ordinary Share American Depositary Receipts including the descriptions of the Pooling
Arrangements in the Company&#146;s Report on Form 8-K filed February&nbsp;13, 2006.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(l)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of the Preference Shares including the descriptions of the American Depositary Receipts and the
Pooling Arrangements in the Company&#146;s Report on Form 8-K filed February&nbsp;13, 2006.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left">(m)</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>The description of the Preference Share American Depositary Receipts including the descriptions of the Pooling
Arrangements in the Company&#146;s Report on Form 8-K filed February&nbsp;13, 2006.</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, all reports on Form 20-F which we file with the SEC and, to the extent, if any,
designated therein, certain reports on Form 6-K which we furnish to the SEC after the date of this
prospectus and prior to the termination of the offering of the shares offered hereby, shall be
deemed to be incorporated by reference in this prospectus from the date of filing or furnishing of
such documents or reports, to the extent not superseded by documents or reports subsequently filed
or furnished.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will provide without charge to each person, including any beneficial owner, to whom this
prospectus is delivered, upon written or oral request of such person, a copy of any or all of the
documents referred to above which have been or may be incorporated by reference (other than certain
exhibits to such documents). Any request should be made in writing or by telephone to the
appropriate party at one of the following addresses:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="35%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">In North America</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Elsewhere</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Fresenius Medical Care North America
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Fresenius Medical Care AG &#038; Co. KGaA</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Investor Relations
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Investor Relations</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">95 Hayden Avenue
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Else-Kr&#246;ner-Strasse 1</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Lexington, MA 02420
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">D. 61352 Bad Homburg, Germany</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Attn: Heinz Schmidt
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attn: Oliver Maier</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Toll Free: 1(800) 662-1237
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#043;&#043; 49 6172 609-2601</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any statement contained herein or in a document, all or a portion of which is incorporated or
deemed to be incorporated by reference herein, shall be deemed to be modified or superseded for
purposes of this Registration Statement to the extent that a statement contained herein or in any
other subsequently filed document which also is or is deemed to be incorporated by reference herein
modifies or supersedes such statement. Any such statement so modified or superseded shall not be
deemed, except as so modified or amended, to constitute a part of this Registration Statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;4.<U> Description of Securities</U></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;5.<U> Interests of Named Experts and Counsel</U></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of the securities offered hereunder was passed upon by Messrs.&nbsp;N&#246;rr
Steifenhofer Lutz of Munich, Germany. Dr.&nbsp;Dieter Schenk, the deputy chairman of the supervisory
board of the Registrant and of Fresenius Medical Care Management AG, the general partner of the
Registrant, is a member of the supervisory board of Fresenius AG, which owns 100% of the share
capital of the general partner of the Registrant. Dr.&nbsp;Schenk is also one of the executors of the
estate of Mrs.&nbsp;Else Kr&#246;ner. The Else-Kr&#246;ner Fresenius Stiftung, a charitable foundation
established under the will of Mrs.&nbsp;Kr&#246;ner, owns the majority of the voting shares of
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Fresenius AG. The foundation&#146;s voting rights are exercised by the executors of Mrs.&nbsp;Kr&#246;ner&#146;s estate, currently
Dr.&nbsp;Dieter Schenk and Dr.&nbsp;Karl Schneider (another member of the Fresenius AG supervisory board).
Dr. h.c. Hans Kr&#246;ner has resigned as executor of the estate; the court will appoint an additional
executor to replace Dr. h.c. Hans Kr&#246;ner. Dr.&nbsp;Bernd Fahrholz, also a member of the supervisory
board of Fresenius Medical Care Management AG and of the Registrant, was a member
of N&#246;rr Steifenhofer Lutz until September&nbsp;30, 2005.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;6.<U> Indemnification of Directors and Officers</U></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under
German law, FMC-AG &#38; Co. KGaA may indemnify its officers and, under certain
circumstances, German labor law requires it to do so. However, the Registrant may not, as a general
matter, indemnify members of its supervisory board or members of the management board or
supervisory board of its general partner. It may, however, purchase directors and officers
insurance. FMC-AG &#38; Co. KGaA has arranged for such insurance coverage at what it believes
to be commercially reasonable rates, terms and conditions. Such insurance is subject to any
mandatory restrictions imposed by German law. In addition, German law may permit a corporation to
indemnify a member of its management or supervisory board or a partnership limited by shares to
indemnify members of its supervisory board or members of the management board or supervisory board
of its general partner for attorneys&#146; fees incurred if such member is the successful party in a
suit in a country such as the U.S., where winning parties are required to bear their own costs, if
German law would have required the losing party to pay such member&#146;s attorney&#146;s fees had the suit
been brought in Germany.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;7.<U> Exemption from Registration Claimed</U></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Not Applicable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;8.<U> Exhibits</U></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The following is a list of exhibits filed as part of this Registration Statement.
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">4.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Form of Articles of Association of Fresenius Medical Care AG
&#38; Co. KGaA (incorporated by reference to Appendix
A to the prospectus of Fresenius Medical Care AG and Fresenius
Medical Care AG &#38; Co. KGaA dated July&nbsp;20, 2005
(Registration No.&nbsp;333-124759) filed July&nbsp;20, 2005).</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">5.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Opinion of N&#246;rr Stiefenhofer Lutz, as to the legality of the securities being registered.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">23.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Consent of KPMG Deutsche Treuhand-Gesellschaft Aktiengesellschaft Wirtschaftspr&#252;fungsgesellschaft.</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">23.2</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Consent of N&#246;rr Stiefenhofer Lutz (included in Exhibit&nbsp;5.1)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">24.1</TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Power of Attorney (included on the signature page herein).</TD>
</TR>

</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9.<U> Undertakings</u></B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Registrant hereby undertakes:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(1)&nbsp;to file, during any period in which offers or sales are being made, a post-effective amendment
to this Registration Statement:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) to include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) to reflect in the prospectus any facts or events arising after the effective date of
the Registration Statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set forth
in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20%
change in the maximum aggregate offering price set forth in the &#147;Calculation of Registration
Fee&#148; table in the effective registration statement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) to include any material information with respect to the plan of distribution not
previously disclosed in the Registration Statement or any material change to such information
in the Registration Statement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%"><I>provided, however</I>, that paragraphs (1)(i) and (1)(ii) do not apply if the Registration
Statement is on Form S-3, Form S-8 or Form F-3 and the information required to be included in a
post-effective amendment by those paragraphs is contained in reports filed with or furnished to
the Commission by the Registrant pursuant to Section&nbsp;13 or Section 15(d) of the Securities
Exchange Act of 1934 that are incorporated by reference in the Registration Statement, or is
contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the
registration statement;
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(2)&nbsp;that, for the purpose of determining any liability under the Securities Act of 1933, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(3)&nbsp;to remove from registration by means of a post-effective amendment any of the securities being
registered which remain unsold at the termination of the offering.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Registrant hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the Registrant&#146;s annual report pursuant to Section 13(a) or Section
15(d) of the Securities Exchange Act that is incorporated by reference in this Registration
Statement shall be deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the registrant pursuant to the
foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in
the Act and is, therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the registrant of expenses incurred or paid by a
director, officer or controlling person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with
the securities being registered, the registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Act and
will be governed by the final adjudication of such issue.
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized in Bad Homburg, Germany on this 14&nbsp;day of February, 2006.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="50%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="33%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="12%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><B>FRESENIUS MEDICAL CARE MANAGEMENT AG</B>, as
general partner of Fresenius Medical Care AG
&#038; Co. KGaA, a partnership limited by shares
created upon the transformation of legal form
of Fresenius Medical Care AG</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Lawrence A. Rosen</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name: Lawrence A. Rosen
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title: Member of the Management Board</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Rice Powell</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title: Member of the Management Board</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>POWER OF ATTORNEY</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below
constitutes and appoints Dr.&nbsp;Ben J. Lipps and Dr.&nbsp;Rainer Runte, and each of them, as his or her
true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for
him or her and in his or her name, place and stead, in any and all capacities, to sign any and all
amendments (including pre-effective and post-effective amendments) to this Registration Statement,
and to file the same, with all exhibits thereto and all documents in connection therewith, with the
Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and
authority to do and perform each and every act and thing requisite and necessary to be done in and
about the premises, as fully to all intents and purposes as he or she may or could do in person,
hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or
substitutes, may lawfully do or cause to be done by virtue hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, as amended, this registration
statement has been signed by the following persons in the capacities and on the dates indicated:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="20%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Signature</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Title</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Date</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->

<TR valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>


<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Ben J. Lipps
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dr.&nbsp;Ben J. Lipps
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chairman of the
Management Board of
Fresenius Medical
Care Management AG
(&#147;Management AG&#148;),
general partner of
Fresenius Medical
Care AG &#038; Co. KGaA,
a partnership
limited by shares
created upon the
transformation of
legal form of
Fresenius Medical
Care AG
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">February&nbsp;14, 2006</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Lawrence A. Rosen
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lawrence A. Rosen
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Member of the
Management Board
(Chief Financial
Officer ) and
principal
accounting officer
of Management AG
and authorized
representative of
Fresenius Medical
Care AG &#038; Co. KGaA
in the United
States KGaA
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">February&nbsp;14, 2006</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Roberto Fust&#233;
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Roberto Fust&#233;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Member of the
Management Board of
Management AG
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">February&nbsp;14, 2006</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Emmanule Gatti
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dr.&nbsp;Emmanuele Gatti
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Member of the
Management Board of
Management AG
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">February&nbsp;14, 2006</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Rainer Runte
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dr.&nbsp;Rainer Runte
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Member of the
Management Board of
Management AG
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">February&nbsp;14, 2006</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Rice Powell
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rice Powell
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Member of the
Management Board of
Management AG
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">February&nbsp;14, 2006</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Mats Wahlstrom
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mats Wahlstrom
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Member of the
Management Board of
Management AG
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">February&nbsp;14, 2006</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXHIBIT INDEX</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="93%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left"><B>Exhibit Description </B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Articles of Association of
Fresenius Medical Care AG &#38; Co. KGaA (incorporated by reference to
Appendix&nbsp;A to the prospectus of Fresenius Medical Care AG and
Fresenius Medical Care AG &#38; Co. KGaA dated
July&nbsp;20, 2005 (Registration No.&nbsp;333-124759) filed July&nbsp;20, 2005).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of N&#246;rr Stiefenhofer Lutz, as to the legality of the securities being registered.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of KPMG Deutsche Treuhand-Gesellschaft Aktiengesellschaft Wirtschaftspr&#252;fungsgesellschaft.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of N&#246;rr Stiefenhofer Lutz (included in Exhibit&nbsp;5.1)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (included on the signature page herein).</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "y16875s8sv8.htm", "description": "S-8", "secsgml_size_bytes": 53009}]
{"company-data": {"conformed-name": "Fresenius Medical Care AG & Co. KGaA", "cik": "0001333141", "assigned-sic": "8090", "irs-number": "000000000"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-131840", "film-number": "06613691"}, "business-address": {"street1": "ELSE-KROENER STRASSE 1", "city": "BAD HOMBURG", "state": "2M", "zip": "61352", "phone": "011-49-6172-6090"}, "mail-address": {"street1": "ELSE-KROENER STRASSE 1", "city": "BAD HOMBURG", "state": "2M", "zip": "61352"}}
S-8
As filed with the Securities and Exchange Commission on February 14, 2006
Registration No. 333-
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
FRESENIUS
MEDICAL CARE & CO. AG
KOMMANDITGESELLSCHAFT auf AKTIEN (KGaA)
(Exact name of registrant as specified in its charter)
FRESENIUS MEDICAL CARE AG & Co. KGaA
(Translation of Registrant's Name into English)
Germany
(State or other jurisdiction of
incorporation or organization)
Not Applicable
(I.R.S. Employer
Identification No.)
Else-Kröner-Strasse 1
61352 Bad Homburg v.d.H., Germany
Telephone: 011-49-6172-609-0
(Address of Principal Executive offices, including Zip Code)
FRESENIUS MEDICAL CARE AG 1996 STOCK INCENTIVE PLAN
FRESENIUS MEDICAL CARE AG 1998 STOCK INCENTIVE PLAN
FRESENIUS MEDICAL CARE AKTIENGESELLSCHAFT 2001 INTERNATIONAL STOCK INCENTIVE PLAN
(Full Title of the Plan)
Dr. Ben J. Lipps
Fresenius Medical Care Holdings, Inc.
95 Hayden Avenue
Lexington, MA 02420
(781) 402-9000
(Name, Address, including Zip Code, and Telephone Number, including Area Code, of Agent for Service)
Copy to:
Charles F. Niemeth, Esq.
Baker & McKenzie LLP
1114 Avenue of the Americas
New York, New York 10036
(212) 626-4100
CALCULATION OF REGISTRATION FEE
Proposed
Proposed
Amount
maximum
maximum
Amount of
to be
offering price
aggregate
registration
Title of securities to be registered
registered
per share
offering price
fee (2)
Ordinary Shares, no par value(1)
2,849,318
$108.67
$309,635,387
$33,130.44
Preference Shares, no par value(1)
2,986,203
$102.04
$304,712,154
$32,605.56
Total:
$65,736.00
(1)
American Depositary Receipts evidencing American Depositary Shares ("ADSs") issuable upon
deposit of the Ordinary Shares and Preference Shares registered hereby have been registered
under separate registration statements on Form F-6.
(2)
The Proposed Maximum Aggregate Offering Price (estimated solely for purposes of computing the
registration fee) is calculated pursuant to Rule 457(h) under the Securities Act of 1933, as
amended, computed based upon a market value of €91.05 per
ordinary share and
€85.50 per preference share, calculated in each case by taking the average of the high and low prices
for such shares on the Frankfurt Stock Exchange on February 8, 2006, converted to U.S. dollars
at the noon buying rate of €1.00 = $1.935, as determined by the Board of Governors of the
Federal Reserve System on February 8, 2006.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The document(s) containing the information specified in Part I of Form S-8 (plan
information and registrant information) will be sent or given to the participating employees as
specified by Rule 428(b)(1) of the Securities Act of 1933, as amended (the "Securities Act"). Such
documents need not be filed with the Securities and Exchange Commission either as part of this
Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424. These
documents, which include the statement of availability required by Item 2 of Form S-8, and the
documents incorporated by reference herein pursuant to Item 3 of Form S-8 (Part II hereof), as
applied to foreign issuers, taken together, constitute a prospectus that meets the requirements of
Section 10(a) of the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference
The following documents, which have been filed by Fresenius Medical Care
Aktiengesellschaft ("
Fresenius Medical Care AG
", or the "
Predecessor
"), the predecessor entity to
Fresenius Medical Care AG & Co. Kommanditgesellschaft auf Aktien
("
FMC-AG & Co. KGaA
" or
the "
Registrant
"), with the Securities and Exchange Commission (the "
Commission
"), are incorporated
in this registration statement by reference, except as superseded or modified as described herein:
(a)
The Predecessor's latest annual report on Form 20-F (Commission file No. 001-14444) for the fiscal year ended
December 31, 2004, filed with the Commission on March 1, 2005.
(b)
The Predecessor's amended annual report on Form 20-F/A (Commission file No. 001-14444) for the fiscal year ended
December 31, 2004, filed with the Commission on July 13, 2005.
(c)
The Predecessor's report on Form 6-K for the month of July 2005, furnished to the Commission on July 5, 2005.
(d)
The Predecessor's report on Form 6-K for the month of November 2005, furnished to the Commission on November 3, 2005
and containing the Predecessor's financial statements as of and for the nine months ended September 30, 2005.
(e)
The Predecessor's report on Form 6-K for the month of November 2005, furnished to the Commission on November 29, 2005.
(f)
The Predecessor's report on Form 6-K for the month of December 2005, furnished to the Commission on December 1, 2005.
(g)
The Predecessor's report on Form 6-K for the month of December 2005, furnished to the Commission on December 22, 2005.
(h)
The Predecessor's report on Form 6-K for the month of December 2005, furnished to the Commission on December 23, 2005.
(i)
The Predecessor's report on Form 6-K for the month of January 2006, furnished to the Commission on January 3, 2006.
(j)
The description of the Ordinary Shares, including the descriptions of the American Depositary Receipts and the
Pooling Arrangements in the Company's Report on Form 8-K filed February 13, 2006.
(k)
The description of the Ordinary Share American Depositary Receipts including the descriptions of the Pooling
Arrangements in the Company's Report on Form 8-K filed February 13, 2006.
(l)
The description of the Preference Shares including the descriptions of the American Depositary Receipts and the
Pooling Arrangements in the Company's Report on Form 8-K filed February 13, 2006.
(m)
The description of the Preference Share American Depositary Receipts including the descriptions of the Pooling
Arrangements in the Company's Report on Form 8-K filed February 13, 2006.
In addition, all reports on Form 20-F which we file with the SEC and, to the extent, if any,
designated therein, certain reports on Form 6-K which we furnish to the SEC after the date of this
prospectus and prior to the termination of the offering of the shares offered hereby, shall be
deemed to be incorporated by reference in this prospectus from the date of filing or furnishing of
such documents or reports, to the extent not superseded by documents or reports subsequently filed
or furnished.
We will provide without charge to each person, including any beneficial owner, to whom this
prospectus is delivered, upon written or oral request of such person, a copy of any or all of the
documents referred to above which have been or may be incorporated by reference (other than certain
exhibits to such documents). Any request should be made in writing or by telephone to the
appropriate party at one of the following addresses:
In North America
Elsewhere
Fresenius Medical Care North America
Fresenius Medical Care AG & Co. KGaA
Investor Relations
Investor Relations
95 Hayden Avenue
Else-Kröner-Strasse 1
Lexington, MA 02420
D. 61352 Bad Homburg, Germany
Attn: Heinz Schmidt
Attn: Oliver Maier
Toll Free: 1(800) 662-1237
++ 49 6172 609-2601
Any statement contained herein or in a document, all or a portion of which is incorporated or
deemed to be incorporated by reference herein, shall be deemed to be modified or superseded for
purposes of this Registration Statement to the extent that a statement contained herein or in any
other subsequently filed document which also is or is deemed to be incorporated by reference herein
modifies or supersedes such statement. Any such statement so modified or superseded shall not be
deemed, except as so modified or amended, to constitute a part of this Registration Statement.
Item 4.
Description of Securities
Not applicable.
Item 5.
Interests of Named Experts and Counsel
The validity of the securities offered hereunder was passed upon by Messrs. Nörr
Steifenhofer Lutz of Munich, Germany. Dr. Dieter Schenk, the deputy chairman of the supervisory
board of the Registrant and of Fresenius Medical Care Management AG, the general partner of the
Registrant, is a member of the supervisory board of Fresenius AG, which owns 100% of the share
capital of the general partner of the Registrant. Dr. Schenk is also one of the executors of the
estate of Mrs. Else Kröner. The Else-Kröner Fresenius Stiftung, a charitable foundation
established under the will of Mrs. Kröner, owns the majority of the voting shares of
Fresenius AG. The foundation's voting rights are exercised by the executors of Mrs. Kröner's estate, currently
Dr. Dieter Schenk and Dr. Karl Schneider (another member of the Fresenius AG supervisory board).
Dr. h.c. Hans Kröner has resigned as executor of the estate; the court will appoint an additional
executor to replace Dr. h.c. Hans Kröner. Dr. Bernd Fahrholz, also a member of the supervisory
board of Fresenius Medical Care Management AG and of the Registrant, was a member
of Nörr Steifenhofer Lutz until September 30, 2005.
Item 6.
Indemnification of Directors and Officers
Under
German law, FMC-AG & Co. KGaA may indemnify its officers and, under certain
circumstances, German labor law requires it to do so. However, the Registrant may not, as a general
matter, indemnify members of its supervisory board or members of the management board or
supervisory board of its general partner. It may, however, purchase directors and officers
insurance. FMC-AG & Co. KGaA has arranged for such insurance coverage at what it believes
to be commercially reasonable rates, terms and conditions. Such insurance is subject to any
mandatory restrictions imposed by German law. In addition, German law may permit a corporation to
indemnify a member of its management or supervisory board or a partnership limited by shares to
indemnify members of its supervisory board or members of the management board or supervisory board
of its general partner for attorneys' fees incurred if such member is the successful party in a
suit in a country such as the U.S., where winning parties are required to bear their own costs, if
German law would have required the losing party to pay such member's attorney's fees had the suit
been brought in Germany.
Item 7.
Exemption from Registration Claimed
Not Applicable.
Item 8.
Exhibits
The following is a list of exhibits filed as part of this Registration Statement.
4.1
Form of Articles of Association of Fresenius Medical Care AG
& Co. KGaA (incorporated by reference to Appendix
A to the prospectus of Fresenius Medical Care AG and Fresenius
Medical Care AG & Co. KGaA dated July 20, 2005
(Registration No. 333-124759) filed July 20, 2005).
5.1
Opinion of Nörr Stiefenhofer Lutz, as to the legality of the securities being registered.
23.1
Consent of KPMG Deutsche Treuhand-Gesellschaft Aktiengesellschaft Wirtschaftsprüfungsgesellschaft.
23.2
Consent of Nörr Stiefenhofer Lutz (included in Exhibit 5.1)
24.1
Power of Attorney (included on the signature page herein).
Item 9.
Undertakings
The Registrant hereby undertakes:
(1) to file, during any period in which offers or sales are being made, a post-effective amendment
to this Registration Statement:
(i) to include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii) to reflect in the prospectus any facts or events arising after the effective date of
the Registration Statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set forth
in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20%
change in the maximum aggregate offering price set forth in the "Calculation of Registration
Fee" table in the effective registration statement; and
(iii) to include any material information with respect to the plan of distribution not
previously disclosed in the Registration Statement or any material change to such information
in the Registration Statement;
provided, however
, that paragraphs (1)(i) and (1)(ii) do not apply if the Registration
Statement is on Form S-3, Form S-8 or Form F-3 and the information required to be included in a
post-effective amendment by those paragraphs is contained in reports filed with or furnished to
the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Securities
Exchange Act of 1934 that are incorporated by reference in the Registration Statement, or is
contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the
registration statement;
(2) that, for the purpose of determining any liability under the Securities Act of 1933, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof; and
(3) to remove from registration by means of a post-effective amendment any of the securities being
registered which remain unsold at the termination of the offering.
The Registrant hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section
15(d) of the Securities Exchange Act that is incorporated by reference in this Registration
Statement shall be deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the registrant pursuant to the
foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in
the Act and is, therefore, unenforceable. In the event that a claim for indemnification against
such liabilities (other than the payment by the registrant of expenses incurred or paid by a
director, officer or controlling person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with
the securities being registered, the registrant will, unless in the opinion of its counsel the
matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Act and
will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized in Bad Homburg, Germany on this 14 day of February, 2006.
FRESENIUS MEDICAL CARE MANAGEMENT AG
, as
general partner of Fresenius Medical Care AG
& Co. KGaA, a partnership limited by shares
created upon the transformation of legal form
of Fresenius Medical Care AG
By:
/s/ Lawrence A. Rosen
Name: Lawrence A. Rosen
Title: Member of the Management Board
By:
/s/ Rice Powell
Name:
Title: Member of the Management Board
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below
constitutes and appoints Dr. Ben J. Lipps and Dr. Rainer Runte, and each of them, as his or her
true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for
him or her and in his or her name, place and stead, in any and all capacities, to sign any and all
amendments (including pre-effective and post-effective amendments) to this Registration Statement,
and to file the same, with all exhibits thereto and all documents in connection therewith, with the
Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and
authority to do and perform each and every act and thing requisite and necessary to be done in and
about the premises, as fully to all intents and purposes as he or she may or could do in person,
hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or
substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this registration
statement has been signed by the following persons in the capacities and on the dates indicated:
Signature
Title
Date
/s/ Ben J. Lipps
Dr. Ben J. Lipps
Chairman of the
Management Board of
Fresenius Medical
Care Management AG
("Management AG"),
general partner of
Fresenius Medical
Care AG & Co. KGaA,
a partnership
limited by shares
created upon the
transformation of
legal form of
Fresenius Medical
Care AG
February 14, 2006
/s/ Lawrence A. Rosen
Lawrence A. Rosen
Member of the
Management Board
(Chief Financial
Officer ) and
principal
accounting officer
of Management AG
and authorized
representative of
Fresenius Medical
Care AG & Co. KGaA
in the United
States KGaA
February 14, 2006
/s/ Roberto Fusté
Roberto Fusté
Member of the
Management Board of
Management AG
February 14, 2006
/s/ Emmanule Gatti
Dr. Emmanuele Gatti
Member of the
Management Board of
Management AG
February 14, 2006
/s/ Rainer Runte
Dr. Rainer Runte
Member of the
Management Board of
Management AG
February 14, 2006
/s/ Rice Powell
Rice Powell
Member of the
Management Board of
Management AG
February 14, 2006
/s/ Mats Wahlstrom
Mats Wahlstrom
Member of the
Management Board of
Management AG
February 14, 2006
EXHIBIT INDEX
Exhibit
Number
Exhibit Description
4.1
Form of Articles of Association of
Fresenius Medical Care AG & Co. KGaA (incorporated by reference to
Appendix A to the prospectus of Fresenius Medical Care AG and
Fresenius Medical Care AG & Co. KGaA dated
July 20, 2005 (Registration No. 333-124759) filed July 20, 2005).
5.1
Opinion of Nörr Stiefenhofer Lutz, as to the legality of the securities being registered.
23.1
Consent of KPMG Deutsche Treuhand-Gesellschaft Aktiengesellschaft Wirtschaftsprüfungsgesellschaft.
23.2
Consent of Nörr Stiefenhofer Lutz (included in Exhibit 5.1)
24.1
Power of Attorney (included on the signature page herein).